Probing the degradation of pharmaceuticals in urine using MFC and studying their removal efficiency by UPLC-MS/MS

被引:1
|
作者
Priya Sharma [1 ]
Devendra Kumar [2 ,3 ]
Srikanth Mutnuri [1 ]
机构
[1] Applied Environmental Biotechnology Laboratory, Birla Institute of Technology & Science (BITS)
[2] Central Sophisticated Instrumentation Facility, Birla Institute of Technology & Science (BITS)
[3] Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center
关键词
Pharmaceuticals; Urine; MFC; Biodegradation; Liquid chromatography mass spectroscopy;
D O I
暂无
中图分类号
X703 [废水的处理与利用]; TM911.45 [生物化学燃料电池、微生物燃料电池];
学科分类号
0808 ; 083002 ;
摘要
Nutrient recovery from source-separated human urine has attracted interest as it is rich in nitrogen and phosphorus that can be utilized as fertilizer. However, urine also contains pharmaceuticals, steroid hormones, etc. and their removal is crucial as they have detrimental effects on the environment and human health. The current study focuses on investigating the degradation of pharmaceuticals using a double-chamber microbial fuel cell(MFC). Urine was spiked with four pharmaceuticals(trimethoprim,lamivudine, levofloxacin, and estrone) at a concentration of 2 mg/mL. The MFC was operated for 7 months in batch mode with this spiked urine as feed. The degradation efficiency of the MFC was studied, for which a selective liquid chromatography-tandem mass-spectrometric method was developed for the quantitation of compounds used in the spiking experiments and was validated with a lower limit of quantification of 0.39 ng/mL. The maximum removal rate achieved was 96% ± 2%. The degradation mechanism involved processes like sorption and anoxic biodegradation. The voltage curve obtained showed that the presence of pharmaceuticals had an initial negative impact on power generation along with increased organic content; however, after the reactor acclimatization, increased power output was achieved with maximum organics removal at 30 h of retention time. This work opens a new perspective for the anoxic biodegradation of pharmaceuticals and can be useful in future bioremediation studies.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [1] Probing the degradation of pharmaceuticals in urine using MFC and studying their removal efficiency by UPLC-MS/MS
    Sharma, Priya
    Kumar, Devendra
    Mutnuri, Srikanth
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2021, 11 (03) : 320 - 329
  • [2] Determination of Cocaine Metabolites and the Adulterant Levamisole in Urine Using UPLC-MS/MS
    Abou-Diwan, Charbel
    Koch, David D.
    Ritchie, James C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (03) : 463 - 463
  • [3] Human urine contamination with environmental pollutants: simultaneous determination using UPLC-MS/MS
    Beltifa, Asma
    Machreki, Monia
    Ghorbel, Asma
    Belaid, Afifa
    Smaoui, Emna
    Akrout, Feriele Messadi
    Di Bella, Giuseppa
    Khdary, Nezar H.
    Reyns, Tim
    Ben Mansour, Hedi
    Van Loco, Joris
    JOURNAL OF WATER AND HEALTH, 2019, 17 (03) : 371 - 379
  • [4] Global metabolic profiling procedures for urine using UPLC-MS
    Want, Elizabeth J.
    Wilson, Ian D.
    Gika, Helen
    Theodoridis, Georgios
    Plumb, Robert S.
    Shockcor, John
    Holmes, Elaine
    Nicholson, Jeremy K.
    NATURE PROTOCOLS, 2010, 5 (06) : 1005 - 1018
  • [5] A Rapid Method for the Determination of Buprenorphine and Norbuprenorphine in Urine by UPLC-MS/MS
    Kul, Aykut
    Ozdemir, Murat
    Ozilhan, Selma
    Sagirli, Olcay
    CURRENT PHARMACEUTICAL ANALYSIS, 2021, 17 (07) : 926 - 931
  • [6] QUANTIFICATION OF GLYCOSAMINOGLYCANS IN HUMAN URINE AND MOUSE TISSUE BY UPLC-MS/MS
    Young, S. P.
    Zhang, H.
    Wood, T.
    Fu, H.
    Auray-Blais, C.
    Koeberl, D. D.
    Millington, D. S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S88 - S88
  • [7] Quantification of glycosaminoglycans in human urine and mouse tissue by UPLC-MS/MS
    Zhang, Haoyue
    Wood, Tim
    Fu, Haiyan
    Auray-Blais, Christiane
    Young, Sarah P.
    Koeberl, Dwight
    Millington, David S.
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (03) : 365 - 366
  • [8] Determination of bifonazole and identification of its photocatalytic degradation products using UPLC-MS/MS
    Kryczyk, Agata
    Zmudzki, Pawel
    Hubicka, Urszula
    BIOMEDICAL CHROMATOGRAPHY, 2017, 31 (09)
  • [10] UPLC-MS/MS High-Risk Screening for Sphingolipidoses Using Dried Urine Spots
    Martineau, Tristan
    Maranda, Bruno
    Auray-Blais, Christiane
    BIOMOLECULES, 2024, 14 (12)